Klotz L - Search Results

1

Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Klein EA, Thompson IM Jr, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, Minasian LM, Ford LG, Parnes HL, Gaziano JM, Karp DD, Lieber MM, Walther PJ, Klotz L, Parsons JK, Chin JL, Darke AK, Lippman SM, Goodman GE, Meyskens FL Jr, Baker LH. Klein EA, et al. Among authors: klotz l. JAMA. 2011 Oct 12;306(14):1549-56. doi: 10.1001/jama.2011.1437. JAMA. 2011. PMID: 21990298 Free PMC article. Clinical Trial.

2

Randomized, prospective, controlled study comparing radical prostatectomy alone and neoadjuvant androgen withdrawal in the treatment of localized prostate cancer. Canadian Urologic Oncology Group.

Goldenberg SL, Klotz LH, Srigley J, Jewett MA, Mador D, Fradet Y, Barkin J, Chin J, Paquin JM, Bullock MJ, Laplante S. Goldenberg SL, et al. Among authors: klotz lh. J Urol. 1996 Sep;156(3):873-7. J Urol. 1996. PMID: 8709351 Clinical Trial.

3

Long-term followup of a randomized trial of 0 versus 3 months of neoadjuvant androgen ablation before radical prostatectomy.

Klotz LH, Goldenberg SL, Jewett MA, Fradet Y, Nam R, Barkin J, Chin J, Chatterjee S; Canadian Uro-Oncology Group. Klotz LH, et al. J Urol. 2003 Sep;170(3):791-4. doi: 10.1097/01.ju.0000081404.98273.fd. J Urol. 2003. PMID: 12913699 Clinical Trial.

4

Synergistic effect of vitamin E and selenium in human prostate cancer cell lines.

Venkateswaran V, Fleshner NE, Klotz LH. Venkateswaran V, et al. Among authors: klotz lh. Prostate Cancer Prostatic Dis. 2004;7(1):54-6. doi: 10.1038/sj.pcan.4500707. Prostate Cancer Prostatic Dis. 2004. PMID: 14745439

5

Multicenter phase II study of combined neoadjuvant docetaxel and hormone therapy before radical prostatectomy for patients with high risk localized prostate cancer.

Chi KN, Chin JL, Winquist E, Klotz L, Saad F, Gleave ME. Chi KN, et al. Among authors: klotz l. J Urol. 2008 Aug;180(2):565-70; discussion 570. doi: 10.1016/j.juro.2008.04.012. Epub 2008 Jun 12. J Urol. 2008. PMID: 18554663 Clinical Trial.

6

Active surveillance for prostate cancer.

Thompson IM, Klotz L. Thompson IM, et al. Among authors: klotz l. JAMA. 2010 Dec 1;304(21):2411-2. doi: 10.1001/jama.2010.1761. JAMA. 2010. PMID: 21119090 Free PMC article. No abstract available.

7

Prospective multi-institutional study evaluating the performance of prostate cancer risk calculators.

Nam RK, Kattan MW, Chin JL, Trachtenberg J, Singal R, Rendon R, Klotz LH, Sugar L, Sherman C, Izawa J, Bell D, Stanimirovic A, Venkateswaran V, Diamandis EP, Yu C, Loblaw DA, Narod SA. Nam RK, et al. Among authors: klotz lh. J Clin Oncol. 2011 Aug 1;29(22):2959-64. doi: 10.1200/JCO.2010.32.6371. Epub 2011 Jun 20. J Clin Oncol. 2011. PMID: 21690464

8

Early prostate cancer--treat or watch?

Klotz L, Thompson I. Klotz L, et al. N Engl J Med. 2011 Aug 11;365(6):569. doi: 10.1056/NEJMc1106325. N Engl J Med. 2011. PMID: 21830972 No abstract available.

9

Canadian Consensus Conference: The FDA decision on the use of 5ARIs.

Klotz L, Chetner M, Chin J, Finelli T, Fleshner N, Fradet Y, Goldenberg L, Nickel JC, Siemens R, So A, Sugar L, Zlotta A, Klein E, Parnes H, Penson D. Klotz L, et al. Can Urol Assoc J. 2012 Apr;6(2):83-8. doi: 10.5489/cuaj.12058. Can Urol Assoc J. 2012. PMID: 22511412 Free PMC article. No abstract available.

10

Re: Active surveillance versus surgery for low risk prostate cancer: a clinical decision analysis: D. Liu, H. P. Lehmann, K. D. Frick and H. B. Carter. J Urol 2012; 187: 1241-1246.

Klotz L, Thompson I. Klotz L, et al. J Urol. 2012 Oct;188(4):1400; author reply 1400. doi: 10.1016/j.juro.2012.06.044. Epub 2012 Aug 18. J Urol. 2012. PMID: 22906654 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,040 results

Search Page